GlaxoSmithKline (GSK), a global leading healthcare company, formally introduced to the Philippine market their branded paracetamol Panadol.
Panadol with Optizorb is a pain reliever sold in more than 85 countries. It sold 15 billion tablets worldwide in last year alone.
“Pain is one of the greatest personal, social and economic burdens faced by people around the world,” said John Sayers, President Consumer Healthcare, Asia, Pacific and Latin America, GSK. “Panadol has helped people find pain relief across 85 countries for over 50 years and today we are pleased to bring this leading paracetamol brand to Philippines’ consumers. This is a significant milestone for GSK in line with our global commitment to help people do more, feel better and live longer.
Panadol with Optizorb is the only paracetamol brand with the unique Optizorb disintegration system which allows the release of its medicine in as little as five minutes vs. regular paracetamol tablets.
Studies conducted by GSK have proven that 75 percent of people who take Panadol with Optizorb caplets reach pain relieving levels of paracetamol in the bloodstream significantly faster than those taking other generic pain relieving brands.
“The brand is testament to our customers’ trust and faith in the product which boasts an extensive scientific research breakthrough such as the Optizorb technology in our new Panadol which is the first and only paracetamol product that contains Optizorb,” added Sayers.
With a greater rate of absorption, (paracetamol) Panadol with Optizorb delivers therapeutic concentrations to most people suffering from a variety of pain even those with common medical conditions, such as stomach problems and heart disease.
“Following a study conducted in Philippines, we found that seven out of ten Filipinos suffer from regular headaches, and over half from muscle aches and pains in the past three months. These pain sufferers have indicated fast relief of pain is of core importance and this has encouraged us to provide a fast and effective solution like Panadol with Optizorb to alleviate this health condition,” said Jeoffrey Yulo, General Manager Consumer Healthcare, GSK Philippines.
Panadol with Optizorb comes in 36 x 10s dispenser box and each 10s catch cover has an SRP of P32.00 and will be available at all leading drugstores nationwide, starting February 2014.
For more information on pain management, visit www.Panadol.com.
